Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Allara Health vs No BS RX

By GLP-1 ScorecardUpdated

Allara HealthFactor scores not reassessed.
Site position #103

Lower score

No BS RXFactor scores not reassessed.
Site position #23

Higher score

Score comparison

No BS RX has the higher recorded score — 82.8/100 to 71.2/100.

No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. No BS RX publishes separate prices for standard compounded, low-dose and brand-name programs.

Before you choose

Allara Health does not publish a semaglutide price, so its Allara Health review sets out what it does disclose, while the No BS RX review explains the conditions attached to No BS RX's figure. The semaglutide cost page compares published rates across the field. Ask Allara Health for a written total before treating either one as the cheaper choice.

If neither one fits, Allara Health vs PCOS Sisters and Alloy vs No BS RX compare each of them with another graded program, and the list of alternatives to Allara Health ranks the programs closest to Allara Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Direct Meds review covers one graded close to these two, at 77.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNo BS RX +24
68
92
Dose & formulationNo BS RX +14
76
90
Clinical oversightAllara Health +13
85
72
Labs & monitoringNo BS RX +7
61
68
FulfillmentNo BS RX +24
70
94
Contract termsNo BS RX +19
55
74
Allara Health · top barNo BS RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAllara HealthNo BS RX
WeighScore71.2/10082.8/100
GradeCB−
Site position#103#23
SemaglutideBrand Wegovy options; confirm separate medication price$149/mo advertised for standard compounded injection; low-dose priced separately
TirzepatideBrand Zepbound options; confirm separate medication price$225/mo advertised for standard compounded injection; low-dose priced separately
CoverageCoverage not publishedConfirm program availability for your state
Brand-name accessYesYes
Oral / sublingualYesYes
Allara Health

Site position #103 · C

Factor scores not reassessed.

Strengths

  • Publishes separate prices for Complete Care and Nutrition
  • Lists branded injectable and oral prescription options

What to consider

  • Care pricing does not establish a drug or testing total
  • Availability and insurance depend on the patient and plan
  • Dashboard cancellation requires notice before the next billing cycle
No BS RX

Site position #23 · B−

Factor scores not reassessed.

Strengths

  • Displays monthly and prepaid amounts by program
  • Advertises consultation, medication, shipping and messaging in the compounded plans
  • Lists branded Ozempic and Zepbound separately

What to consider

  • The $115 headline applies to low-dose programs
  • Plans renew automatically at the then-current rate
  • Cancellation generally stops future billing without refunding the current period

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard